NA89
NOTICE OF ACCEPTANCE OF SEC. 8 & 9 - E-MAILED
17/01/2020
Voltar para busca
Dado oficial do USPTO
RENCELL
Sabia que essa marca já está registrada no Estados Unidos?
Antes de investir em nome, identidade e divulgação, valide risco de colisão e estratégia de registro para não perder tempo nem budget.
Active USPTO registrationTipo: VerbalEscritório: Estados Unidos
Diagnóstico de risco e oportunidade
Leitura executiva para decisão de naming, protocolo e monitoramento.
Situação USPTO
Active USPTO registration
Tipo de processo
Pedido e registro
Eventos registrados
52
Atualização mais recente
17/01/2020
Tipo de marca
Verbal
Classes Nice
1, 5
Data de depósito
02/04/2007
Data de registro
16/03/2010
Data de expiração
-
Dados completos do processo
Campos estruturados da autoridade responsável e do histórico oficial.
Data da situação
17/01/2020
Última transação
17/01/2020
Escritório responsável
United States Patent and Trademark Office
Código da situação
800
Cadastro oficial
Principal Register
Fundamento do pedido
Intent to use, Foreign priority
Código do desenho
4
Tipo de titular
03
Localização do titular
Pencoed, Brigend, GB
Examinador
BENJAMIN, SARA NICOLE
Unidade examinadora
M10
Localização atual
GENERIC WEB UPDATE
Titulares e representantes
Titulares
ReNeuron Limited
ReNeuron Limited
Representantes
Mainak H. Mehta Procopio, Cory, Hargreaves & Savitch LLP
Classificação técnica
Classes Nice
Classe 1Classe 5
Códigos Vienna
Sem códigos Vienna disponíveis.
Produtos e serviços
Classe 1
Cells for scientificlaboratory and medical research; human cells for scientificlaboratory and medical research; stem cells for scientificlaboratory and medical research; encapsulated cells for scientificlaboratory and medical research; encapsulated cell aggregates for scientificlaboratory and medical research; microcapsules and macrocapsules containing cells or cell aggregates for scientificlaboratory and medical research
Classe 5
Cells for medical or clinical use; human cells for medical or clinical use; stem cells for medical or clinical use; encapsulated cells for medical or clinical use; encapsulated cell aggregates for medical or clinical use; encapsulated cells for use in cell-based medical therapies; microcapsules and macrocapsules containing cells or cell aggregates for medical or clinical use
Publicações
Histórico de despachos e eventos da marca no USPTO.
52 publicações encontradas
RNL1
REGISTERED AND RENEWED (FIRST RENEWAL - 10 YRS)
17/01/2020
89AG
REGISTERED - SEC. 8 (10-YR) ACCEPTED/SEC. 9 GRANTED
17/01/2020
E89R
TEAS SECTION 8 & 9 RECEIVED
14/01/2020
NA85
NOTICE OF ACCEPTANCE OF SEC. 8 & 15 - MAILED
18/11/2016
C15P
REGISTERED - PARTIAL SEC. 8 (6-YR) ACCEPTED & SEC. 15 ACK.
18/11/2016
APRE
CASE ASSIGNED TO POST REGISTRATION PARALEGAL
18/11/2016
E815
TEAS SECTION 8 & 15 RECEIVED
09/09/2016
R.PR
REGISTERED-PRINCIPAL REGISTER
16/03/2010
NPUB
OFFICIAL GAZETTE PUBLICATION CONFIRMATION E-MAILED
29/12/2009
PUBO
PUBLISHED FOR OPPOSITION
29/12/2009
PREV
LAW OFFICE PUBLICATION REVIEW COMPLETED
24/11/2009
CNSA
APPROVED FOR PUB - PRINCIPAL REGISTER
05/11/2009
XAEC
EXAMINER'S AMENDMENT ENTERED
04/11/2009
GNEN
NOTIFICATION OF EXAMINERS AMENDMENT E-MAILED
03/11/2009
GNEA
EXAMINERS AMENDMENT E-MAILED
03/11/2009
CNEA
EXAMINERS AMENDMENT -WRITTEN
03/11/2009
GNRN
NOTIFICATION OF NON-FINAL ACTION E-MAILED
09/10/2009
GNRT
NON-FINAL ACTION E-MAILED
09/10/2009
CNRT
NON-FINAL ACTION WRITTEN
09/10/2009
TEME
TEAS/EMAIL CORRESPONDENCE ENTERED
17/09/2009
CRFA
CORRESPONDENCE RECEIVED IN LAW OFFICE
17/09/2009
ERSI
TEAS RESPONSE TO SUSPENSION INQUIRY RECEIVED
17/09/2009
GNS2
NOTIFICATION OF INQUIRY AS TO SUSPENSION E-MAILED
30/04/2009
GNSI
INQUIRY TO SUSPENSION E-MAILED
30/04/2009
CNSI
SUSPENSION INQUIRY WRITTEN
30/04/2009
RCCK
SUSPENSION CHECKED - TO ATTORNEY FOR ACTION
30/04/2009
GNS3
NOTIFICATION OF LETTER OF SUSPENSION E-MAILED
30/10/2008
GNSL
LETTER OF SUSPENSION E-MAILED
30/10/2008
CNSL
SUSPENSION LETTER WRITTEN
30/10/2008
DMCC
DATA MODIFICATION COMPLETED
29/10/2008
TEME
TEAS/EMAIL CORRESPONDENCE ENTERED
07/10/2008
CRFA
CORRESPONDENCE RECEIVED IN LAW OFFICE
07/10/2008
ERSI
TEAS RESPONSE TO SUSPENSION INQUIRY RECEIVED
07/10/2008
GNS2
NOTIFICATION OF INQUIRY AS TO SUSPENSION E-MAILED
07/07/2008
GNSI
INQUIRY TO SUSPENSION E-MAILED
07/07/2008
CNSI
SUSPENSION INQUIRY WRITTEN
07/07/2008
RCCK
SUSPENSION CHECKED - TO ATTORNEY FOR ACTION
02/07/2008
GNS3
NOTIFICATION OF LETTER OF SUSPENSION E-MAILED
02/01/2008
GNSL
LETTER OF SUSPENSION E-MAILED
02/01/2008
CNSL
SUSPENSION LETTER WRITTEN
02/01/2008
TEME
TEAS/EMAIL CORRESPONDENCE ENTERED
10/12/2007
CRFA
CORRESPONDENCE RECEIVED IN LAW OFFICE
10/12/2007
TROA
TEAS RESPONSE TO OFFICE ACTION RECEIVED
10/12/2007
GNRN
NOTIFICATION OF NON-FINAL ACTION E-MAILED
17/07/2007
GNRT
NON-FINAL ACTION E-MAILED
17/07/2007
CNRT
NON-FINAL ACTION WRITTEN
17/07/2007
DOCK
ASSIGNED TO EXAMINER
16/07/2007
AMPX
PRELIMINARY/VOLUNTARY AMENDMENT - ENTERED
16/05/2007
ALIE
ASSIGNED TO LIE
16/05/2007
PARI
TEAS VOLUNTARY AMENDMENT RECEIVED
24/04/2007
NWAP
NEW APPLICATION ENTERED
05/04/2007
Proteção contínua da sua marca
Seja avisado a cada novo depósito que ameace RENCELL ou a sua marca.
Vigilância profissional por 24 meses: monitoramos o USPTO por você e alertamos a tempo de você se opor — antes que o conflito vire prejuízo.